Larson Financial Group’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
DGM
Larson Financial Group's GMAB Position: Q3 2026 in Review
Larson Financial Group increased its Genmab (GMAB) stake by 6.3% in Q3 2026, buying an estimated $380 and bringing the position to 201 shares worth $7.17K. The position accounts for ﹤0.01% of the portfolio, ranked #2684.
Larson Financial Group first reported a position in GMAB in Q3 2023 and has held it in 6 quarters since. 331 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- Larson Financial Group held 201 shares of Genmab worth $7.17K as of Q3 2026.
- Larson Financial Group bought 12 Genmab shares in Q3 2026, an estimated $380.
- Genmab made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2684 holding.
- Larson Financial Group first reported a position in Genmab in Q3 2023 and has held it in 6 quarters since.
- 331 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.